glutathione iron and parkinson& 39 Glutathione, Parkinson's disease Ferroptosis in Parkinson's disease: glia–neuron

Bardini, et al

While numerous studies have emphasized its antioxidant, anti-inflammatory, and nephroprotective properties, there is insufficient consensus on the specific bioactive components responsible for these effects or their precise mechanisms of action

Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report

In all models, the following fixed covariates were entered: assigned treatment (investigational product or placebo), baseline measurement of the outcome of interest, visit (day 14 1 day or day 28 1 day), visit in interaction with treatment, period (period 1 or period 2), sex and, for MIDT outcomes, incentive level